Simone Odília Antunes Fernandes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Simone Odília Antunes Fernandes has a total of 441 co-authors. Here are the top co-authors by number of shared publications:
Valbert Nascimento Cardoso
Department of Clinical and Toxicological Analyses, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil
25 shared publications- Valbert Nascimento Cardoso
Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
16 shared publications - Leonardo Lima Fuscaldi
Hospital Israelita Albert Einstein, São Paulo, Brazil
12 shared publications - André Luís Branco de Barros
Federal University of Minas Gerais Av. Antônio Carlos, 6627
10 shared publications - Flaviano Santos Martins
Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
10 shared publications - Valbert Nascimento Cardoso
Universidade Federal de Minas Gerais
10 shared publications
Latest Publications
- Open Access
- 5 September 2026
- Published by Elsevier in SSRN Electronic Journal
Development and Characterization of Novel Biodegradable Wound Dressings Containing Stryphnodendron adstringens Extract
The management of complex wounds, such as burns, pressure ulcers, and chronic skin lesions, remains a major healthcare challenge owing to their prolonged healing process and high susceptibility to complications. These injuries frequently require extended hospitalization, increase the incidence of infections and surgical interventions, and compromise patients' functional capacity and quality of life. Furthermore, currently available wound dressings are often constrained by elevated manufacturing costs, inconsistent therapeutic performance, and reliance on imported biomaterials. To address these challenges, a bioactive wound dressing based on Stryphnodendron adstringens (barbatimão), a medicinal plant recognized by the Brazilian Pharmacopoeia for its wound-healing, anti-inflammatory, antioxidant, and antimicrobial properties, was developed. A standardized plant-derived active pharmaceutical ingredient was obtained through an optimized extraction process and successfully incorporated into a biocompatible polymeric matrix. The engineered membrane was designed to recreate an optimal wound microenvironment by maintaining moisture balance, permitting gas exchange, providing a protective barrier against external contaminants, and enabling sustained release of bioactive phytochemicals to prolong their therapeutic action. The developed biomaterials were thoroughly characterized using Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR), X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), Differential Thermal Analysis (DTA), Scanning Electron Microscopy (SEM), hydration studies, in vitro release assays, mechanical testing, and cytotoxicity evaluation. Overall, the membranes exhibited excellent physicochemical stability, favorable biocompatibility, and efficient incorporation and sustained release of natural bioactive compounds, demonstrating considerable promise for advanced biomedical and wound healing applications.
- 5 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDevelopment and Characterization of Novel Biodegradable Wound Dressings Containing Stryphnodendron adstringens Extract
The management of complex wounds, such as burns, pressure ulcers, and chronic skin lesions, remains a major healthcare challenge owing to their prolonged healing process and high susceptibility to complications. These injuries frequently require extended hospitalization, increase the incidence of infections and surgical interventions, and compromise patients' functional capacity and quality of life. Furthermore, currently available wound dressings are often constrained by elevated manufacturing costs, inconsistent therapeutic performance, and reliance on imported biomaterials. To address these challenges, a bioactive wound dressing based on Stryphnodendron adstringens (barbatimão), a medicinal plant recognized by the Brazilian Pharmacopoeia for its wound-healing, anti-inflammatory, antioxidant, and antimicrobial properties, was developed. A standardized plant-derived active pharmaceutical ingredient was obtained through an optimized extraction process and successfully incorporated into a biocompatible polymeric matrix. The engineered membrane was designed to recreate an optimal wound microenvironment by maintaining moisture balance, permitting gas exchange, providing a protective barrier against external contaminants, and enabling sustained release of bioactive phytochemicals to prolong their therapeutic action. The developed biomaterials were thoroughly characterized using Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR), X-ray Diffraction (XRD), Thermogravimetric Analysis (TGA), Differential Thermal Analysis (DTA), Scanning Electron Microscopy (SEM), hydration studies, in vitro release assays, mechanical testing, and cytotoxicity evaluation. Overall, the membranes exhibited excellent physicochemical stability, favorable biocompatibility, and efficient incorporation and sustained release of natural bioactive compounds, demonstrating considerable promise for advanced biomedical and wound healing applications.
- Open Access
- 21 May 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Comparative preventive effects of probiotic and postbiotic preparations of Lacticaseibacillus rhamnosus L156.4 and GG in a 5-FU-induced mucositis model
Intestinal mucositis is a severe chemotherapy side effect, affecting up to 90% of patients. 1 It results from inflammation of the intestinal mucosa and is a common consequence of anticancer treatme...
- 21 May 2026
- Published by Taylor & Francis in Gut Microbes Reports
- Vol. 3 (1)
Open AccessComparative preventive effects of probiotic and postbiotic preparations of Lacticaseibacillus rhamnosus L156.4 and GG in a 5-FU-induced mucositis model
Intestinal mucositis is a severe chemotherapy side effect, affecting up to 90% of patients. 1 It results from inflammation of the intestinal mucosa and is a common consequence of anticancer treatme...
- Open Access
Protective role of Probiatop® in mitigating 5-fluorouracil-induced intestinal mucositis in mice
- 14 October 2025
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (4) , 3019-3027
Limosilactobacillus reuteri UN41 improves the survival rate and exhibits hepatoprotective effects in a murine model of Salmonella infection
Salmonellosis poses a significant public health threat, potentially leading to severe complications, ranging from enteritis to life-threatening septicemia. Salmonella enterica ssp. enterica serovar Typhimurium has the ability to translocate from the intestine to the liver via the hepatic portal system, causing severe lesions in the organ. The development of new treatment strategies is crucial, due to clinical burden of this infection. In this context, probiotics have emerged as a promising therapeutic avenue due to their multifaceted mechanisms of action. The aim of this study was to investigate the probiotic potential of two strains of Limosilactobacillus reuteri (UN34 and UN41) in a murine model of salmonellosis. Although both strains demonstrated in vitro characteristics indicative of potential probiotics, only the UN41 strain improved the survival rate of mice infected with S. Typhimurium, highlighting that the probiotic effect is strain-specific. In the in vivo model, administration of UN41 also attenuated neutrophilic infiltration, reduced bacterial translocation to the liver, lowered AST levels, and mitigated liver injury. These findings underscore the potential of L. reuteri UN41 as a promising probiotic candidate for mitigating the impact of salmonellosis.
- 14 October 2025
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (4) , 3019-3027
Limosilactobacillus reuteri UN41 improves the survival rate and exhibits hepatoprotective effects in a murine model of Salmonella infection
Salmonellosis poses a significant public health threat, potentially leading to severe complications, ranging from enteritis to life-threatening septicemia. Salmonella enterica ssp. enterica serovar Typhimurium has the ability to translocate from the intestine to the liver via the hepatic portal system, causing severe lesions in the organ. The development of new treatment strategies is crucial, due to clinical burden of this infection. In this context, probiotics have emerged as a promising therapeutic avenue due to their multifaceted mechanisms of action. The aim of this study was to investigate the probiotic potential of two strains of Limosilactobacillus reuteri (UN34 and UN41) in a murine model of salmonellosis. Although both strains demonstrated in vitro characteristics indicative of potential probiotics, only the UN41 strain improved the survival rate of mice infected with S. Typhimurium, highlighting that the probiotic effect is strain-specific. In the in vivo model, administration of UN41 also attenuated neutrophilic infiltration, reduced bacterial translocation to the liver, lowered AST levels, and mitigated liver injury. These findings underscore the potential of L. reuteri UN41 as a promising probiotic candidate for mitigating the impact of salmonellosis.
- Open Access
- 28 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 2166
Vagus Nerve Mediated Liver-Brain-Axis Is a Major Regulator of the Metabolic Landscape in the Liver
The liver serves as a major energetic reservoir for other tissues and its metabolic function is controlled by humoral and neural factors. The vagus nerve innervating the gastrointestinal tract plays an important role in regulating peripheral metabolism and energy expenditure. Although the liver receives vagus nerve fibers, the impact of this circuitry in the regulation of hepatic metabolism is still poorly understood. Herein, we used a combination of quantitative proteomics and in vivo imaging techniques to investigate the impact of the vagus nerve on liver metabolism in male mice. Liver-brain axis was impaired by vagotomy (VNX) or knocking down of the vesicular acetylcholine transporter (VAChT-KD). Mice were challenged with high carbohydrate or high-fat feeding. The vagus nerve shapes the metabolic framework of the liver, as vagotomy led to a significant alteration of the hepatic proteome landscape. Differential protein expression and pathway enrichment analyses showed that glycolytic and fatty acid biosynthesis were increased following VNX, whereas β-oxidation was decreased. These results were corroborated in VAChT-KD mice. This metabolic shift facilitated lipid accumulation in hepatocytes in mice fed with a standard commercial diet. Furthermore, VNX worsened liver steatosis following high-carbohydrate or high-fat dietary challenges. This study describes the liver-brain axis mediated by the vagus nerve as an important regulator of the hepatic metabolic landscape.
- 28 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 2166
Open AccessVagus Nerve Mediated Liver-Brain-Axis Is a Major Regulator of the Metabolic Landscape in the Liver
The liver serves as a major energetic reservoir for other tissues and its metabolic function is controlled by humoral and neural factors. The vagus nerve innervating the gastrointestinal tract plays an important role in regulating peripheral metabolism and energy expenditure. Although the liver receives vagus nerve fibers, the impact of this circuitry in the regulation of hepatic metabolism is still poorly understood. Herein, we used a combination of quantitative proteomics and in vivo imaging techniques to investigate the impact of the vagus nerve on liver metabolism in male mice. Liver-brain axis was impaired by vagotomy (VNX) or knocking down of the vesicular acetylcholine transporter (VAChT-KD). Mice were challenged with high carbohydrate or high-fat feeding. The vagus nerve shapes the metabolic framework of the liver, as vagotomy led to a significant alteration of the hepatic proteome landscape. Differential protein expression and pathway enrichment analyses showed that glycolytic and fatty acid biosynthesis were increased following VNX, whereas β-oxidation was decreased. These results were corroborated in VAChT-KD mice. This metabolic shift facilitated lipid accumulation in hepatocytes in mice fed with a standard commercial diet. Furthermore, VNX worsened liver steatosis following high-carbohydrate or high-fat dietary challenges. This study describes the liver-brain axis mediated by the vagus nerve as an important regulator of the hepatic metabolic landscape.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (1) , 108-119
Biodistribution and Tumor Targeted Accumulation of Anti-CEA-loaded Iron Nanoparticles
Introduction: Active targeting of tumors by nanomaterials favors early diagnosis and the reduction of harsh side effects of chemotherapeuticals Methods: We synthesized magnetic nanoparticles (64 nm; -40 mV) suspended in a magnetic fluid (MF) and decorated them with anti-carcinoembryonic antigen (MFCEA; 144 nm; -39 mV). MF and MFCEA nanoparticles were successfully radiolabeled with technetium–99m (99mTc) and intravenously injected in CEA-positive 4T1 tumor-bearing mice to perform biodistribution studies. Both 99mTc-MF and 99mTc-MFCEA had marked uptake by the liver and spleen, and the renal uptake of 99mTc-MFCEA was higher than that observed for 99mTc-MF at 20h. At 1 and 5 hours, the urinary excretion was higher for 99mTc-MF than for 99mTc-MFCEA. Results: These data suggest that anti-CEA decoration might be responsible for a delay in renal clearance. Regarding the tumor, 99mTc-MFCEA showed tumor uptake nearly two times higher than that observed for 99mTc-MFCEA. Similarly, the target-nontarget ratio was higher with 99mTc-MFCEA when compared to the group that received the 99mTc-MF. Conclusion: These data validated the ability of active tumor targeting by the as-developed anti- CEA loaded nanoparticles and are very promising results for the future development of a nanodevice for the management of breast cancer and other types of CEA-positive tumors.
- 1 January 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (1) , 108-119
Biodistribution and Tumor Targeted Accumulation of Anti-CEA-loaded Iron Nanoparticles
Introduction: Active targeting of tumors by nanomaterials favors early diagnosis and the reduction of harsh side effects of chemotherapeuticals Methods: We synthesized magnetic nanoparticles (64 nm; -40 mV) suspended in a magnetic fluid (MF) and decorated them with anti-carcinoembryonic antigen (MFCEA; 144 nm; -39 mV). MF and MFCEA nanoparticles were successfully radiolabeled with technetium–99m (99mTc) and intravenously injected in CEA-positive 4T1 tumor-bearing mice to perform biodistribution studies. Both 99mTc-MF and 99mTc-MFCEA had marked uptake by the liver and spleen, and the renal uptake of 99mTc-MFCEA was higher than that observed for 99mTc-MF at 20h. At 1 and 5 hours, the urinary excretion was higher for 99mTc-MF than for 99mTc-MFCEA. Results: These data suggest that anti-CEA decoration might be responsible for a delay in renal clearance. Regarding the tumor, 99mTc-MFCEA showed tumor uptake nearly two times higher than that observed for 99mTc-MFCEA. Similarly, the target-nontarget ratio was higher with 99mTc-MFCEA when compared to the group that received the 99mTc-MF. Conclusion: These data validated the ability of active tumor targeting by the as-developed anti- CEA loaded nanoparticles and are very promising results for the future development of a nanodevice for the management of breast cancer and other types of CEA-positive tumors.
- 7 September 2024
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17 (4) , 2133-2144
Oral Treatment with Saccharomyces cerevisiae CNCM I-3856 Mitigates the Inflammatory Response Experimentally Induced by Salmonella enterica subsp. enterica Serovar Typhimurium in Mice
Salmonella spp. are intracellular, Gram-negative pathogens responsible for a range of diarrheal diseases, which can present either as self-limited (gastroenteritis) or as a systemic form (typhoid fever), characterizing a serious public health problem. In this study, we investigated the therapeutic effects of oral administration of Saccharomyces cerevisiae CNCM I-3856 in a murine model infected with Salmonella Typhimurium (ST). This yeast species has previously demonstrated the potential to support immune function and reduce inflammation and the ability to exert antimicrobial activity, which is important considering the increasing prevalence of antibiotic-resistant bacteria. Our findings revealed that mice infected with ST and only treated with sterile saline exhibited a higher mortality rate and body weight loss. In contrast, mice treated with I-3856 showed a notable reduction in these adverse outcomes. The yeast demonstrated a high capacity for co-aggregation with the pathogen. Furthermore, the significant amounts of yeast found in the feces of treated mice suggest that intestinal colonization was effective, which was associated with several beneficial effects, including reduced intestinal permeability, which likely limits bacterial translocation to extraintestinal organs. Additionally, the administration of I-3856 reduced levels of sIgA and resulted in a decrease in the recruitment of neutrophils and eosinophils to infection sites, indicating a modulation of the inflammatory response. Histological analyses showed attenuated liver and intestinal lesions in the yeast-treated mice, corroborating the protective effects of the yeast. In conclusion, the results suggest that S. cerevisiae CNCM I-3856 has the potential to control the inflammatory response experimentally induced by S. Typhimurium when administered to mice.
- 7 September 2024
- Published by Springer Nature in Probiotics and Antimicrobial Proteins
- Vol. 17 (4) , 2133-2144
Oral Treatment with Saccharomyces cerevisiae CNCM I-3856 Mitigates the Inflammatory Response Experimentally Induced by Salmonella enterica subsp. enterica Serovar Typhimurium in Mice
Salmonella spp. are intracellular, Gram-negative pathogens responsible for a range of diarrheal diseases, which can present either as self-limited (gastroenteritis) or as a systemic form (typhoid fever), characterizing a serious public health problem. In this study, we investigated the therapeutic effects of oral administration of Saccharomyces cerevisiae CNCM I-3856 in a murine model infected with Salmonella Typhimurium (ST). This yeast species has previously demonstrated the potential to support immune function and reduce inflammation and the ability to exert antimicrobial activity, which is important considering the increasing prevalence of antibiotic-resistant bacteria. Our findings revealed that mice infected with ST and only treated with sterile saline exhibited a higher mortality rate and body weight loss. In contrast, mice treated with I-3856 showed a notable reduction in these adverse outcomes. The yeast demonstrated a high capacity for co-aggregation with the pathogen. Furthermore, the significant amounts of yeast found in the feces of treated mice suggest that intestinal colonization was effective, which was associated with several beneficial effects, including reduced intestinal permeability, which likely limits bacterial translocation to extraintestinal organs. Additionally, the administration of I-3856 reduced levels of sIgA and resulted in a decrease in the recruitment of neutrophils and eosinophils to infection sites, indicating a modulation of the inflammatory response. Histological analyses showed attenuated liver and intestinal lesions in the yeast-treated mice, corroborating the protective effects of the yeast. In conclusion, the results suggest that S. cerevisiae CNCM I-3856 has the potential to control the inflammatory response experimentally induced by S. Typhimurium when administered to mice.
- 6 May 2024
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 37 (2) , 175-192
Atorvastatin attenuates intestinal mucositis induced by 5-fluorouracil in mice by modulating the epithelial barrier and inflammatory response
Chemotherapy-induced intestinal mucositis is a major side effect of cancer treatment. Statins are 3-hydroxy-3-methyl glutaryl coenzyme reductase inhibitors used to treat hypercholesterolemia and atherosclerotic diseases. Recent studies have demonstrated that atorvastatin (ATV) has antioxidant, anti-inflammatory, and resulting from the regulation of different molecular pathways. In the present study, we investigated the effects of ATV on intestinal homeostasis in 5-fluorouracil (5-FU)-induced mucositis. Our results showed that ATV protected the intestinal mucosa from epithelial damage caused by 5-FU mainly due to inflammatory infiltrate and intestinal permeability reduction, downregulation of inflammatory markers, such as Tlr4, MyD88, NF-κB, Tnf-a, Il1β, and Il6 dose-dependent. ATV also improved epithelial barrier function by upregulating the mRNA transcript levels of mucin 2 (MUC2), and ZO-1 and occludin tight junction proteins. The results suggest that the ATV anti-inflammatory and protective effects on 5-FU-induced mice mucositis involve the inhibition of the TLR4/MYD88/NPRL3/NF-κB, iNos, and caspase 3.
- 6 May 2024
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 37 (2) , 175-192
Atorvastatin attenuates intestinal mucositis induced by 5-fluorouracil in mice by modulating the epithelial barrier and inflammatory response
Chemotherapy-induced intestinal mucositis is a major side effect of cancer treatment. Statins are 3-hydroxy-3-methyl glutaryl coenzyme reductase inhibitors used to treat hypercholesterolemia and atherosclerotic diseases. Recent studies have demonstrated that atorvastatin (ATV) has antioxidant, anti-inflammatory, and resulting from the regulation of different molecular pathways. In the present study, we investigated the effects of ATV on intestinal homeostasis in 5-fluorouracil (5-FU)-induced mucositis. Our results showed that ATV protected the intestinal mucosa from epithelial damage caused by 5-FU mainly due to inflammatory infiltrate and intestinal permeability reduction, downregulation of inflammatory markers, such as Tlr4, MyD88, NF-κB, Tnf-a, Il1β, and Il6 dose-dependent. ATV also improved epithelial barrier function by upregulating the mRNA transcript levels of mucin 2 (MUC2), and ZO-1 and occludin tight junction proteins. The results suggest that the ATV anti-inflammatory and protective effects on 5-FU-induced mice mucositis involve the inhibition of the TLR4/MYD88/NPRL3/NF-κB, iNos, and caspase 3.